Related Experiment Video
Updated: Sep 8, 2026

Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice
Published on: March 15, 2024
Drugs to enhance athletic performance in the adolescent
Abstract:
Why would any athlete expose himself to these pharmacologic agents? The most obvious answer is to improve performance. Since athletic performance is composed of so many variables, for example, attitude, diligence in training, strength, agility, and the competitive spirit, it is difficult to ascribe improvement in performance to any particular agent. It may be due to the placebo effect or to better or more efficient training, to say nothing about the effects of the normal maturational process. Certainly the peer pressure of others using these agents weighs heavily upon the adolescent's mind. Might peers have a competitive advantage? All of these points would be moot if it were not for the ready availability of many of these compounds. All are within reach of the athlete with a little knowledge of this subculture, and all are relatively inexpensive (with the exception of GH). They can be as tempting to adolescents as are brightly colored packages of household cleaners, vitamins, or flavored children's aspirin tablets to toddlers. Continuing with this analogy, one notes that most of the time children easily recover from accidental ingestions, but these instances, just as with drugs of adolescent and adult abuse, can be deadly.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

